Black Friday Early Access|Up to 60% Off + Free Worldwide Shipping
Sequencing.com — Outsmart Your Genes

APOE Gene and Alzheimer's: What Genetic Testing Can and Can't Tell You

By Layla Afkhami, MS, content creator and social media manager with over a decade of experience in rare disease testing.

Medically reviewed by Sequencing Team, the team of bioinformaticians, Genetic Health Coaches and writers at Sequencing.com, last reviewed

Nov 16, 2026

APOE Gene and Alzheimer's: What Genetic Testing Can and Can't Tell You

If Alzheimer's runs in your family, it's normal to wonder about your risk. Genetics plays a part in Alzheimer's in two ways. Common variants in the APOE gene can change your risk of developing Alzheimer's. Much rarer changes in genes such as APP, PSEN1 and PSEN2 can cause the disease directly, usually at a younger age. Age, other genes, and lifestyle and health factors all play a role too.

This guide explains what to do if you have a family history of Alzheimer's, what APOE variants mean, how genetic testing works, what a result can and can't tell you, and which next steps are worth considering.

This page is for education only. An APOE status result is not a diagnosis and can't tell you if or when you might develop Alzheimer's, so please talk through any result with a doctor or genetic counselor.

What is the APOE gene?

The APOE gene tells your body how to make a protein called apolipoprotein E, which helps carry fats through your blood and brain. The APOE gene comes in three common variants, ε2, ε3 and ε4 (also written e2, e3 and e4), and you inherit one copy from each parent. The ε3 variant is the most common and is found in more than half of the general population (MedlinePlus Genetics).

Because everyone carries two copies of the APOE gene, there are six possible combinations, called genotypes:

rs429358rs7412APOE statusWhat it means for Alzheimer's risk
T/TC/Cε3/ε3The most common combination, used as the comparison point for risk
T/TC/Tε2/ε3Generally lower risk than ε3/ε3, but not full protection
T/TT/Tε2/ε2Rare, with the lowest Alzheimer's risk of any APOE combination, but linked to a rare cholesterol condition
C/TC/Tε2/ε4Higher risk than ε3/ε3, likely lower than ε3/ε4
C/TC/Cε3/ε4Higher risk
C/CC/Cε4/ε4The highest risk of the common combinations

What does APOE ε3/ε4 mean?

APOE ε3/ε4 means you have one ε3 copy and one ε4 copy of the APOE gene, one inherited from each parent. It's linked to a higher-than-average chance of Alzheimer's, but most people with ε3/ε4 don't develop Alzheimer's, even by age 85, as the figures in the next section show.

What does having the APOE ε4 variant mean?

Having the ε4 variant raises your chance of developing Alzheimer's, and it may mean symptoms start at a younger age (Alzheimer's Association). It's fairly common: about 20% to 30% of people in the United States have at least one copy of ε4, including about 2% who have two (Alzheimer's Association).

The more copies of ε4 you have, the higher your risk. This table shows the estimated chance of developing Alzheimer's by age 85 (Genin et al., Molecular Psychiatry, 2011):

Estimated chance of developing Alzheimer's by age 85

APOE statusMenWomen
General population (average)11%14%
ε3/ε3 (the most common)8%10%
ε3/ε4 (one copy of ε4)23%30%
ε4/ε4 (two copies of ε4)51%60%

Most people with one copy of ε4 don't develop Alzheimer's, even by age 85. Not having ε4 doesn't rule Alzheimer's out: about 42% of people with Alzheimer's have no ε4 copy (GeneReviews).

Research into ε4 is ongoing. A 2024 study of people with two copies of ε4 found that Alzheimer's-related changes in the brain usually began years before any symptoms, which started on average in their mid-60s (Fortea et al., Nature Medicine, 2024). However, brain changes aren't the same as symptoms, and researchers are still refining what this means.

Most of these figures come from people of European ancestry, so ε4 may not carry the same risk for everyone (Mayo Clinic). For example, people of European ancestry can have a higher risk from ε4 than people with some African ancestry, such as African Americans and Caribbean Hispanic people (Alzheimer's Association).

Is Alzheimer's hereditary?

Alzheimer's is hereditary in two different senses. For most people, inherited variants in genes such as APOE affect how likely they are to develop Alzheimer's without deciding whether they will. Only a small number of families have a single gene change that causes the disease directly.

  • Risk gene variants raise or lower your chance of developing the common late-onset form of Alzheimer's but don't decide the outcome. APOE ε4 is the best-known example.
  • Deterministic gene variants cause the disease directly. Disease-causing changes in the APP, PSEN1 or PSEN2 genes lead to a rare familial form of early-onset Alzheimer's, and a parent with one of these changes has a 50% chance of passing it to each child (GeneReviews). They account for 1% or less of cases, and symptoms usually start between a person's early 40s and mid-50s (Alzheimer's Association).

Does my family history of Alzheimer's affect my chances of developing the disease?

Yes, a family history of Alzheimer's can affect your chances of developing the disease, but it doesn't mean you will get it. Having a parent, brother or sister with Alzheimer's raises your risk, and having more than one affected relative raises it further (Alzheimer's Association). GeneReviews estimates a lifetime risk of about 15% to 39% for first-degree relatives (parents, siblings, children) of someone with the common form of Alzheimer's (GeneReviews). This added risk comes partly from shared genes and partly from shared lifestyle and environment.

Thanksgiving, Nov 26, is also National Family Health History Day, which makes it a good moment to ask relatives about your family's health history.

How does Alzheimer's genetic testing work?

Alzheimer's genetic testing works by reading genes linked to Alzheimer's, such as APOE, from a DNA sample. Our Whole Genome Sequencing reads your entire APOE gene, along with the rest of your DNA, from a simple, painless cheek (buccal) swab you collect at home. Within the gene, your APOE status (ε2, ε3 or ε4) comes from two specific spots, called rs429358 and rs7412, which together show which two forms of the gene you have (see the table above).

Because it reads your whole genome, our Whole Genome Sequencing also screens the APP, PSEN1 and PSEN2 genes linked to rare early-onset Alzheimer's. With Sequencing, you receive your Whole Genome Sequencing data for APOE and for these genes. You can compare our Whole Genome Sequencing bundles to find the right test for you.

Is Alzheimer's genetic testing worth it?

Whether Alzheimer's genetic testing is worth it depends on why you want to know. For people without symptoms, experts generally agree APOE testing has little role in telling who will develop Alzheimer's (GeneReviews). For people with memory symptoms, a doctor may use APOE status results alongside other tests as part of a diagnosis (GeneReviews).

APOE testing also now plays a part in treatment decisions. For newer Alzheimer's medicines that clear amyloid from the brain, called anti-amyloid treatments, the FDA-approved labels recommend checking APOE ε4 status before treatment starts. This is because people with two ε4 copies have a higher chance of a side effect called ARIA, which involves swelling or small bleeds in the brain. Testing isn't required to receive treatment, and your doctor will decide which test to use (FDA prescribing information for lecanemab and donanemab).

Many people still find an APOE ε4 result useful for planning or for joining research. Before you test, it helps to know that a federal law called GINA protects against genetic discrimination in health insurance and most employment. It doesn't cover life, disability or long-term care insurance, though some states add protections (National Human Genome Research Institute). The Alzheimer's Association advises that anyone considering genetic testing "should receive genetic counseling before a test is ordered and when the results are obtained" (Alzheimer's Association). You can find a genetic counselor through the National Society of Genetic Counselors.

I have one or two APOE ε4 copies. What should I do?

If you have one or two APOE ε4 copies, start by talking to your doctor or a genetic counselor, who can put your result in context with your age, family history and health. There's no need to make any change based on your APOE status alone. It's also normal to feel worried after an ε4 result, especially if you've watched someone you love live with Alzheimer's.

Next steps could include:

  • Take your time. A genetic result tells you what's in your DNA, but working out what it means for you takes context, so there's no need to act on it straight away (Alzheimer's Association).
  • Bring your results to a clinician. A genetic counselor is trained to explain what results mean for you and your family.
  • Mention any memory concerns. If you or your family have noticed changes in memory or thinking, tell your doctor, because a clinical assessment can look into those changes, and your APOE status can't.
  • Consider talking to your family. Your parents, siblings and children may share your APOE variants. Whether to tell them is your choice, and a genetic counselor can help you plan that conversation.
  • Find support. People with APOE ε4 can find educational information and community support through the Phoenix Community.
  • Learn more about your genetic health. Our Whole Genome Sequencing screens thousands of genetic conditions, including the APP, PSEN1 and PSEN2 genes linked to early-onset Alzheimer's.

Sources

This content is for educational purposes and is not medical advice, a diagnosis or a substitute for care from a qualified clinician.